MEETING OVERVIEW

23rd Annual Innovations in Urologic Practice
Santa Fe, New Mexico
September 14-16, 2018

The 23rd Annual Innovations in Urologic Practice conference will provide a detailed review and commentary on multiple genitourinary and urologic diseases. Among the featured oncological topics are a description of bladder cancer and immunotherapies, as well as upper tract cancer management, prostate cancer, including state-of-the-art imaging, focal therapy, and MRI. Experts will also discuss new tools and techniques for nephrectomy and treating advanced renal cell carcinoma. In terms of general urological approaches, conference sessions will educate attendees on pelvic reconstruction and trauma, men’s health topics like male infertility and sexual dysfunction, and ways to diagnose and treat infections in the urology patient.

PROGRAM DIRECTOR

MOHIT KHERA, MD, MBA, MPH
Associate Professor of Urology
Baylor College of Medicine
Houston, TX

Co-provided by Baylor College of Medicine, the Scott Department of Urology and the University of New Mexico School of Medicine

PROGRAM OVERVIEW

Prostate Cancer
Discussions will focus on early diagnosis and screening of prostate cancer. Specifically, our faculty will debate the role of MRI in prostate biopsies, selecting patients for active surveillance, and guiding targeted focal therapy. Both localized and advanced treatment will be subject to review and commentary.

Bladder Cancer
The program will emphasize case-based decision-making options for MIBC, second-line bladder cancer therapies, lymph node dissection during radical cystectomy, and immunotherapy for bladder cancer.

Other Genitourinary Cancers
Upper tract urothelial cancer and testis cancer management will be discussed as well as new tools and techniques for nephrectomy and treating advanced renal cell carcinoma.

Men’s Health
Our faculty will provide an advanced review and interactive discussion on best practices in penile prosthesis, pelvic reconstruction and trauma, transgender surgery, hypogonadism, urethral strictures, hypospadias, nocturia, male anorgasmia, and new perspectives on treating male infertility. This section will also include updates to the new AUA guidelines on testosterone, erectile dysfunction, and urethral strictures.

MIS/Flank Pain/Renal
This session emphasizes and provides direction on strategies for the successful workup and management of the frustrating clinical conundrum of recurrent flank pain. Attendees will learn about the medical and surgical management of retroperitoneal fibrosis in the minimally invasive era and autosomal dominant polycystic kidney disease.

Infections in Urology
This session focuses on infections in the urology setting, including antimicrobial prophylaxis for transrectal prostate biopsy, management of UTIs, antimicrobial resistance, multi-drug resistant bacteria, 3D printing, VR simulators, genetic engineering, and autologous fascia for pelvic floor reconstruction.

Needs Statement
This conference focuses on current controversies and innovative diagnostic and treatment strategies for some of the most common urologic problems faced by clinical urologists, oncologists, and other healthcare providers who treat patients with urologic diseases. The rapidly changing healthcare environment and pace of technological innovations in medicine require urologists, oncologists, and other healthcare providers to keep abreast of state-of-the-art diagnosis and management of urologic disease.

Learning Objectives
At the conclusion of the activity, participants should be able to:

  • Summarize the most recent American Urological Association guidelines for diagnosis and treatment of men with urethral stricture, testosterone deficiency, or erectile dysfunction
  • Describe and implement how to use MRI to perform prostate biopsy for the diagnosis of prostate cancer
  • Analyze the pros and cons of focal therapy for treatment of prostate cancer
  • Discuss the impact of prescribed testosterone on infertility
  • Evaluate the recent advancements in the treatment of other genitourinary cancers, including bladder cancer, RCC, testis cancer, and UTUC
  • Apply the American Urological Association Guidelines to diagnosing and treating patients with urethral strictures, testosterone deficiency, erectile dysfunction

Target Audiences
This activity is designed for general urologists, oncologists, radiation oncologists, primary care physicians, and other healthcare providers who treat and care for urology patients. For urologists, oncologists, and radiation oncologists, this conference will focus on genitourinary cancer treatment and provide a detailed description of bladder cancer, immunotherapy, UTUC, state of the art imaging, focal therapy, and MRI for prostate cancer, and new tools and techniques for nephrectomy and treating advanced renal cell carcinoma. For general urologists and primary care physicians, there will be a focus on pelvic reconstruction and trauma, men’s health topics dealing with male infertility and sexual dysfunction, and ways to treat infectious conditions in urology.

Educational Methods
Lectures | Case Presentations Question and Answer Sessions | Panel Discussions

Evaluation
Evaluation by questionnaire will address program content, presentation, and possible bias.

Accreditation Statement/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing medical education for physicians. Baylor College of Medicine designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.